Seastar Medical Holding Corp. Receives Nasdaq Notice for Failure to Meet Minimum Bid Price Requirement

Reuters
Aug 06
Seastar Medical Holding Corp. Receives Nasdaq Notice for Failure to Meet Minimum Bid Price Requirement

Seastar Medical Holding Corporation has announced that it received a deficiency letter from the Nasdaq Stock Market's Listing Qualifications Department on July 31, 2025. The letter notified the company that its common stock had failed to meet the minimum $1.00 per share bid price requirement for continued listing on the Nasdaq Capital Market for 30 consecutive business days. This notification does not affect the company's current listing on Nasdaq. Seastar Medical has been given until January 27, 2026, to regain compliance by ensuring the closing bid price of its stock is at least $1.00 for a minimum of 10 consecutive business days. The company is actively monitoring the situation and is considering options to address the issue.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Seastar Medical Holding Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-103274), on August 06, 2025, and is solely responsible for the information contained therein.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10